What is whole genome sequencing and how does it help children like Nathaniel Clayton?

Whole genome sequencing analyzes a person's entire genetic code to identify changes related to health conditions, aiding in earlier diagnoses for rare diseases like KIF1A.

How much faster are diagnoses with new genomic sequencing technology?

Recent studies show children are being diagnosed on average two years earlier, significantly improving access to care and support.

Where can families find support if their child has a rare genetic condition?

Families can access specialist care and support from organizations like the charity Small Steps, which assists children with physical challenges.

Home / Health / Early Diagnosis Powers Families Facing Rare Conditions

Early Diagnosis Powers Families Facing Rare Conditions

2 Dec

•

Summary

Whole genome sequencing diagnoses rare genetic conditions years earlier.
Nathaniel Clayton's family gained 'power' from his KIF1A diagnosis.
New study shows average diagnosis age reduced by two years.

Early Diagnosis Powers Families Facing Rare Conditions

Advances in whole genome sequencing are dramatically accelerating the diagnosis of rare genetic conditions in children. This innovative technology provides a comprehensive readout of an individual's genetic code, enabling earlier identification of specific health-related changes. Families are finding that receiving a diagnosis, even without a cure, provides vital information for care and advocacy.

The case of three-year-old Nathaniel Clayton exemplifies this progress. Diagnosed with the rare neurological condition KIF1A through whole genome sequencing at Great Ormond Street Hospital, his parents gained a clear understanding of his health challenges. This diagnosis empowered them to seek targeted support and plan for his future.

Research published in the journal Genetics in Medicine confirms these improvements, indicating that children diagnosed via the NHS's Genomic Medicine Service are identified at an average age of six, two years earlier than previously. This earlier intervention is crucial for timely access to necessary treatments and specialist care, offering significant hope and better outcomes for affected children and their families.